loading

Cns Pharmaceuticals Inc Borsa (CNSP) Ultime notizie

pulisher
12:29 PM

How CNS Pharmaceuticals Inc. stock performs in weak economy2025 Breakouts & Breakdowns & AI Enhanced Trading Alerts - mfd.ru

12:29 PM
pulisher
Feb 12, 2026

What are analysts’ price targets for CNS Pharmaceuticals Inc.July 2025 Opening Moves & Long Hold Capital Preservation Tips - mfd.ru

Feb 12, 2026
pulisher
Feb 12, 2026

Why CNS Pharmaceuticals Inc. stock is recommended by analystsInsider Selling & Entry Point Strategy Guides - mfd.ru

Feb 12, 2026
pulisher
Feb 12, 2026

CNS Pharmaceuticals (NASDAQ:CNSP) Shares Down 11.2% – Here’s What Happened - Defense World

Feb 12, 2026
pulisher
Feb 10, 2026

Supernus Pharmaceuticals, Inc. (SUPN): Investor Outlook on CNS Drug Innovator with 19.56% Upside Potential - DirectorsTalk Interviews

Feb 10, 2026
pulisher
Feb 08, 2026

CNS Pharmaceuticals Reports Financial Gains Amid Ongoing R&D - MSN

Feb 08, 2026
pulisher
Feb 08, 2026

Growth Report: Will Origin Bancorp Inc outperform the market in YEARPrice Action & Community Verified Trade Signals - baoquankhu1.vn

Feb 08, 2026
pulisher
Feb 08, 2026

Weekly Trades: Why is CNS Pharmaceuticals Inc stock going downJuly 2025 Price Swings & AI Powered Market Entry Strategies - baoquankhu1.vn

Feb 08, 2026
pulisher
Feb 05, 2026

Aug Catalysts: Will CNS Pharmaceuticals Inc outperform small cap indexesQuarterly Earnings Summary & Weekly Hot Stock Watchlists - baoquankhu1.vn

Feb 05, 2026
pulisher
Feb 03, 2026

Vect-Horus Enters a CNS-Focused Research Collaboration with OliX Pharmaceuticals - GlobeNewswire

Feb 03, 2026
pulisher
Feb 01, 2026

CNS Pharmaceuticals shares dip after CEO departure announcement - MSN

Feb 01, 2026
pulisher
Jan 27, 2026

CNS Pharmaceuticals says priority ‘is to transform’ how company operates - TipRanks

Jan 27, 2026
pulisher
Jan 27, 2026

CNS Pharmaceuticals’ new CEO outlines strategic overhaul By Investing.com - Investing.com Canada

Jan 27, 2026
pulisher
Jan 27, 2026

CNS Pharmaceuticals (NASDAQ: CNSP) Issues Shareholder Letter Outlining Strategic Review and Focus on TPI 287 - Digital Journal

Jan 27, 2026
pulisher
Jan 27, 2026

CNS Pharmaceuticals Announces Strategic Review Focused on Lead Drug Candidate TPI 287 - citybuzz -

Jan 27, 2026
pulisher
Jan 27, 2026

CNS Pharmaceuticals (CNSP) CEO Outlines Strategic Vision for Fut - GuruFocus

Jan 27, 2026
pulisher
Jan 27, 2026

CNS Pharmaceuticals’ new CEO outlines strategic overhaul - Investing.com

Jan 27, 2026
pulisher
Jan 27, 2026

CNS Pharmaceuticals Issues Letter to Shareholders - ACCESS Newswire

Jan 27, 2026
pulisher
Jan 27, 2026

New CNS Pharmaceuticals CEO launches broad review built around lead cancer drug - stocktitan.net

Jan 27, 2026
pulisher
Jan 26, 2026

Ovid Therapeutics: Bullish Post-PIPE With 2 Differentiated CNS Moonshots - Seeking Alpha

Jan 26, 2026
pulisher
Jan 23, 2026

Breakout Move: Is CNS Pharmaceuticals Inc stock good for income investorsMarket Volume Report & Daily Risk Controlled Trade Plans - baoquankhu1.vn

Jan 23, 2026
pulisher
Jan 21, 2026

CNS Pharmaceuticals (NASDAQ:CNSP) Stock Price Up 3.3% – What’s Next? - Defense World

Jan 21, 2026
pulisher
Jan 19, 2026

Is CNS Pharmaceuticals Inc. being accumulated by smart money2025 Major Catalysts & Precise Buy Zone Identification - bollywoodhelpline.com

Jan 19, 2026
pulisher
Jan 15, 2026

CNS Pharma Stock Up Over 30% - Nasdaq

Jan 15, 2026
pulisher
Jan 12, 2026

Weekly Trades: Is CNS Pharmaceuticals Inc in a long term uptrendJuly 2025 Fed Impact & Verified Short-Term Plans - baoquankhu1.vn

Jan 12, 2026
pulisher
Jan 09, 2026

How CNS Pharmaceuticals Inc. stock compares to market leadersForecast Cut & AI Optimized Trading Strategy Guides - ulpravda.ru

Jan 09, 2026
pulisher
Jan 08, 2026

How CNS Pharmaceuticals Inc. stock reacts to global recession fears2025 Price Targets & Growth Focused Investment Plans - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

How CNS Pharmaceuticals Inc. stock performs after earningsJuly 2025 Summary & Detailed Earnings Play Alerts - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Should I hold or sell CNS Pharmaceuticals Inc. stock in 2025Earnings Risk Summary & Reliable Volume Spike Alerts - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Dividend Watch: How CNS Pharmaceuticals Inc. stock performs in rate cut cycles2025 Investor Takeaways & Accurate Trade Setup Notifications - Улправда

Jan 08, 2026
pulisher
Jan 02, 2026

CNS Pharmaceuticals Inc. (CNSP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Jan 02, 2026
pulisher
Dec 28, 2025

CNS Pharmaceuticals (NASDAQ:CNSP) Stock Price Down 0.5% – Here’s Why - Defense World

Dec 28, 2025
pulisher
Dec 27, 2025

Aug Reactions: How CNS Pharmaceuticals Inc stock performs in rate cut cycles2025 Top Gainers & Capital Efficient Trading Techniques - moha.gov.vn

Dec 27, 2025
pulisher
Dec 23, 2025

CNS Pharmaceuticals names Rami Levin as new CEO following John Climaco’s departure - MSN

Dec 23, 2025
pulisher
Dec 22, 2025

Whats Driving Tourism Finance Corporation of India Limited Stocks Recent Momentum Key TrendsCandlestick Trading Patterns & High Return Capital Strategies - earlytimes.in

Dec 22, 2025
pulisher
Dec 20, 2025

Why CNS Pharmaceuticals Inc. stock is popular among millennialsJuly 2025 Update & Free Risk Controlled Daily Trade Plans - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Will CNS Pharmaceuticals Inc. stock remain a Wall Street favorite2025 Growth vs Value & Safe Entry Trade Signal Reports - Улправда

Dec 20, 2025
pulisher
Dec 19, 2025

Is CNS Pharmaceuticals Inc. stock positioned well for digital economyQuarterly Earnings Report & High Conviction Buy Zone Picks - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

CNSP (CNS Pharmaceuticals) EV-to-OCF : 0.34 (As of Dec. 19, 2025) - GuruFocus

Dec 19, 2025
pulisher
Dec 18, 2025

CNSP (CNS Pharmaceuticals) EV-to-OCF : 0.34 (As of Dec. 18, 2025) - GuruFocus

Dec 18, 2025
pulisher
Dec 18, 2025

CNS Pharmaceuticals appoints Rami Levin as new CEO, replacing Climaco By Investing.com - Investing.com South Africa

Dec 18, 2025
pulisher
Dec 18, 2025

CNS Pharmaceuticals Announces New CEO Appointment - The Globe and Mail

Dec 18, 2025
pulisher
Dec 17, 2025

CNS Pharmaceuticals (NASDAQ: CNSP) Appoints Rami Levin as President and CEO - Digital Journal

Dec 17, 2025
pulisher
Dec 17, 2025

CNS Pharmaceuticals Appoints Rami Levin as CEO to Advance Brain Cancer Pipeline - citybuzz -

Dec 17, 2025
pulisher
Dec 17, 2025

CNS Pharmaceuticals appoints Rami Levin as CEO, John Climaco resigns By Investing.com - Investing.com Australia

Dec 17, 2025
pulisher
Dec 17, 2025

CNS Pharmaceuticals appoints Rami Levin as CEO effective Jan 1, 2026 - marketscreener.com

Dec 17, 2025
pulisher
Dec 17, 2025

CNS Pharmaceuticals stock falls after CEO steps down - Investing.com India

Dec 17, 2025
pulisher
Dec 17, 2025

CNS Pharmaceuticals stock falls after CEO steps down By Investing.com - Investing.com Nigeria

Dec 17, 2025
pulisher
Dec 17, 2025

CNS Pharmaceuticals appoints Rami Levin as CEO, John Climaco resigns - Investing.com

Dec 17, 2025
$26.45
price down icon 1.12%
$45.19
price up icon 0.87%
$101.10
price up icon 0.35%
$105.87
price up icon 0.10%
$148.75
price up icon 1.77%
biotechnology ONC
$346.07
price down icon 0.10%
Capitalizzazione:     |  Volume (24 ore):